Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04759781

MElanoma Research Lymph Node Prediction Implementation National_001

Sponsor: SkylineDx

View on ClinicalTrials.gov

Summary

MERLIN\_001 is a prospective registry study of a primary melanoma gene-signature to predict sentinel node (SN) status and to determine its prognostic value for more accurate staging of SN-negative melanoma patients.

Official title: A Prospective Registry Study of a Primary Melanoma Gene-signature to Predict Sentinel Node (SN) Status and Determine Its Prognostic Value for More Accurate Staging of SN-negative Melanoma Patients.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1820

Start Date

2021-08-25

Completion Date

2029-06

Last Updated

2024-07-08

Healthy Volunteers

No

Conditions

Locations (9)

Moffitt Cancer Center

Tampa, Florida, United States

Emory University School of Medicine

Atlanta, Georgia, United States

University of Kentucky

Lexington, Kentucky, United States

University of Louisville

Louisville, Kentucky, United States

University of Michigan

Ann Arbor, Michigan, United States

Mayo Clinic

Rochester, Minnesota, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Duke University

Durham, North Carolina, United States

Huntsman Cancer Institute

Salt Lake City, Utah, United States